National Pharmaceutical Pricing Authority (NPPA), the drug regulator in India, has announced increase of stents price by two percent. This decision has been made based on the wholesale price index.
With this increase the metal stents price will increase from the current Rs. 7,260 to Rs. 7400, drug-eluting stent price has been increased from Rs. 29,600 to Rs. 30,180.
A coronary stent will be placed in the arteries to supply blood to the heart. This keeps the arteries open during the treatment of coronary heart diseases.
National Pharmaceutical Pricing Authority (NPPA) is a nodal agency which controls the prices of pharmaceutical drugs in India. The agency works under the purview of Union Ministry of Chemical and Fertilizer.
The agency also monitors supply of drugs, their availability in the market, identifies the shortages and responds accordingly. Under The Drug (Prices Control) Order 2013, NPA determines the rates of various drugs and influx in the market.
Finance Ministry Announces Reduction of Interest Rates on Small Savings by 0.1%(eco)
Indian finance ministry had announced reduction of interest rates by 0.1 percent on saving schemes such as National Savings Certificate (NSC), KisanVikas Patra and Public Provident Fund (PPF) for the April-June quarter.
The reduced interest rate would be applicable to all the nine saving schemes, the interested rates on this schemes would be reviewed on each quarter.
View all contributions by
iDrona with its unique collection of high quality resources provides excellent guidance to its government job aspirant followers. It provides important study material, previous question papers, and all the needed updates related to all the government job exams.